Clinical trials: Pediatric Acute-Onset Neuropsychiatric Syndrome

Pediatric Acute-Onset Neuropsychiatric Syndrome

Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)

• Completed
• Age: 6 to 17 years
• Phase 3
• Results posted

A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome

Trial name

NCT04508530

Testing

Panzyga

Where

12 sites in United States, Italy and 1 more

Volunteers

71 people

Sponsor

Octapharma